Subscribe: MedWorm: Cardiac Arrhythmia
Added By: Feedage Forager Feedage Grade B rated
Language: English
arrhythmia  arrhythmias  cardiac arrhythmia  cardiac arrhythmias  cardiac  device  heart  medical  new  patients  source  system 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: MedWorm: Cardiac Arrhythmia

MedWorm: Cardiac Arrhythmia News provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Cardiac Arrhythmia

Last Build Date: Wed, 31 Jan 2018 13:27:35 +0100


Philips joins $9m round for remote-care co LindaCare

Wed, 24 Jan 2018 17:03:30 +0100

Digital health company LindaCare has landed an $8.7 million Series B round, with investments made by Philips (NYSE:PHG), PMV, Capricorn ICT Arkiv, Connecticut Innovations and others. The Belgium-based company said it plans to use the newly-acquired funds to accelerate its U.S. market expansion and product commercialization, as well as build out its existing patient monitoring software platform for a broader range of cardiac diseases. “This investment is a significant step for us, as it enables LindaCare to execute faster on our ambitious vision and strategy, and to take a leading market position across both Europe and the US,” founder & CEO Shahram Sharif said in prepared remarks. “With Philips onboard as a strategic partner, alongside existing and new venture ca...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Cyclizine is sold in Denmark as an over-the-counter drug and has serious side effects when overdosed - Petersen K, Hjorth P.

Thu, 18 Jan 2018 16:42:31 +0100

Cyclizine is sold in Denmark as an over-the-counter drug and affects not only histaminergic but also muscarinergic, serotonergic and α-adrenergic receptors, with side effects such as respiratory depression and cardiac arrhythmias, leading to fatalities. D... (Source: SafetyLit)

The Startup Caf é, the Place where Healthcare IT Decision-Makers and New Companies can Meet

Tue, 16 Jan 2018 11:00:00 +0100

17 - 19 April 2018, Berlin, Germany. Whether they develop apps that detect the early stages of cardiac arrhythmia or cybersecurity software for hospitals, startups in the healthcare IT sector are flexible, highly innovative and can make a significant contribution to digitalising the healthcare system. (Source: eHealth News EU)

Abbott Expands Portfolio of MRI-Ready Devices

Wed, 03 Jan 2018 19:20:18 +0100

FDA gave MR-conditional labeling to two of Abbott's cardiac rhythm management (CRM) devices, a move that further boosts the company's ability to compete with its peers in the space. The Abbott Park, IL-based firm said patients who receive a Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D) or a Fortify Assura implantable cardioverter defibrillator (ICD) are now able to have an MRI in the future if need be. The Quadra Assura and the Fortify Assura are two of Abbott's most widely-used high voltage devices, the company noted. In September 2016, Abbott won FDA approval for MR-conditional labeling for the Ellipse ICD, which represented the first major step toward closing an important gap that previously existed in St. Jude's portfolio, prior to Abbott and St. Jude merging...

The 8th Annual Alexander Awards: The Best Tox Reading of 2017

Tue, 02 Jan 2018 21:17:32 +0100

Alexander Gettler Once again, last year’s outstanding examples of long-form journalism dealing with topics related to medical toxicology were dominated by coverage of the opioid crisis, its origins and the resulting carnage. The must-read article of the year was “The Family That Built a Empire of Pain,” Patrick Radden Keefe’s massive history of the Sacklers, one of America’s richest clans, much of whose wealth comes from their ownership of Purdue Pharma and the marketing and distribution of Oxycontin. The article, which appeared in the New Yorker, notes that the clan’s patriarch, Arthur Sackler, worked his way through medical school in the 1940s by serving as a copywriter for a New York ad agency that targeted targeted physicians and medical workers. He...

Researchers are developing light therapy as a non-invasive, alternative treatment for disease

Mon, 18 Dec 2017 23:28:54 +0100

(Natural News) Artificial light has both its risks and benefits, but a new study shows that it may be the solution to minimally invasive, drug-free treatments. Researchers are currently developing new ways using infrared neuromodulation to treat cardiac arrhythmia (irregular heart beat), hypertension (high blood pressure), asthma, sleep apnea (suspension of breathing during sleep), diarrhea, and... (Source:

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

Spinal Elements lifts former COO Blain to the corner office | Personnel Moves November 30, 2017

Thu, 30 Nov 2017 20:28:03 +0100

Spinal Elements, previously known as Amendia, said this week it is lifting co-founder and current prez & COO Jason Blain to the position of prez & CEO, effective immediately. Prior to coming on to co-found Spinal Elements, Blain served in various roles with medtech companies Smith & Nephew (NYSE:SNN), Alphatec (NSDQ:ATEC) and NuVasive Inc. (NSDQ:NUVA). Blain is replacing Chris Fair, who will stay on as a board member with the company. “I am excited by the opportunity to lead our talented team of employees and partners and create an even more vibrant and dynamic Spinal Elements in the years to come. I thank Chris Fair and the other members of our board of directors for their confidence. Going forward, Spinal Elements will continue to be focused on innovation and executi...

Shining a light on the nervous system to thwart disease

Tue, 14 Nov 2017 05:00:00 +0100

(Case Western Reserve University) Researchers from Case Western Reserve University School of Medicine, Vanderbilt University, and University of Pittsburgh have received a four-year, $9 million grant from the National Institutes of Health to develop enhanced infrared light technology (infrared neuromodulation) for potentially treating a variety of diseases, including cardiac arrhythmias, high and low blood pressure, asthma, sleep apnea and diarrhea, one of the leading killers of children worldwide. (Source: EurekAlert! - Medicine and Health)

URMC Cardiologist Receives High Honor from American Heart Association

Mon, 13 Nov 2017 22:44:31 +0100

University of Rochester Medical Center cardiologist Arthur J. Moss, M.D., whose research on cardiac arrhythmias has saved countless lives and changed the treatment of heart disease worldwide, was honored with the 2017 James B. Herrick Award at the American Heart Association ’s Scientific Sessions. (Source: University of Rochester Medical Center Press Releases)

Abbott Launches the First and Only Smartphone Compatible Insertable Cardiac Monitor in the U.S.

Mon, 23 Oct 2017 15:27:25 +0100


Abbott wins FDA nod for Confirm Rx smartphone-connected cardiac monitor

Mon, 23 Oct 2017 15:20:39 +0100

Abbott (NYSE:ABT) said today it won FDA clearance for its Confirm Rx insertable cardiac monitor, touting it as the 1st and only smartphone compatible ICM designed to help identify cardiac arrhythmias. The Confirm Rx system includes a sensor designed to be implanted just under the skin over the chest in a minimally-invasive outpatient procedure, the company said. The newly cleared device features incorporated Bluetooth wireless technology to allow patients to connect to the device on their smartphone devices through Abbott’s myMerlin mobile application. Data collected by the device is also transmitted to the patient’s physician on a schedule set by the practitioner, the company said. “Confirm Rx shows what we can do with cutting edge communication technology and the most...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Getting to the heart of mapping arrhythmia-related excitations

Fri, 29 Sep 2017 04:00:00 +0100

(American Institute of Physics) Atrial fibrillation is the most prevalent form of cardiac arrhythmia, affecting up to 6 million people in the US alone. Common treatments for severe forms of the erratic beating phenomenon are controversial, and guided by detection methods that are not yet standardized or fully refined. But research from a group of cross-disciplinary scientists, published this week in the journal Chaos, offers a computational approach to understanding the important factors involved in measuring cardiac excitation waves. (Source: EurekAlert! - Medicine and Health)

Abbott Catches Up to Peers With MRI-Compatible ICD

Sat, 23 Sep 2017 04:38:19 +0100

Abbott Laboratories acquired St. Jude Medical earlier this year knowing that the company trailed behind its peers in the cardiac rhythm management (CRM) space by not having a MRI-compatible pacemaker or implantable cardioverter defibrillator (ICD) system. It seems Abbott has officially caught up in that category though, first with FDA approval of the Assurity MRI pacemaker and the Tendril MRI pacing lead during the first quarter, and now with FDA approval of MRI-conditional labeling for the Ellipse ICD system. Abbott said the recent approval covers one of its most widely-used ICD systems and associated high voltage leads. The approval is for the Ellipse ICD with the Tendril MRI pacing lead and Durata and Optisure high voltage leads. The new labeling allows patients with an Ellipse ICD pati...

Abbott wins MR-conditional label for Ellipse ICDs

Fri, 22 Sep 2017 12:54:06 +0100

Abbott (NYSE:ABT) said today that it won an MR-conditional label from the FDA for the Ellipse implantable cardioverter defibrillator it acquired along with St. Jude Medical early this year. The MR-conditional label applies to Ellipse and the Tendril MRI pacing lead and the Durata and Optisure high-voltage leads, the Chicago-area medical device giant said. “When you consider the number of patients each year who rely on the lifesaving treatment delivered by an ICD device, it is critical to continually innovate to provide new benefits to people battling complex arrhythmias and other cardiac conditions,” cardiac arrhythmias & heart failure CMO Dr. Mark Carlson said in prepared remarks. “By expanding our portfolio of MRI-compatible devices, we’re adding another benef...

Is BioSig for Real This Time With Its Pure EP?

Thu, 07 Sep 2017 19:48:33 +0100

A couple years ago, BioSig Technologies, Inc. was poised to apply for FDA clearance to market its technology to improve treatment of atrial fibrillation and ventricular tachycardia. Then its scientific advisors advised the Minneapolis company to put more work into that technology, a hardware-software combination designed to present clearer signals during electrophysiology studies and catheter ablation. The technology, Pure EP, is designed to cut through the background noise of the lab and its equipment during cardiac recordings, enabling physicians to target and neutralize the areas of the heart that are causing atrial fibrillation (Afib), and ventricular tachycardia (VT), according to BioSig. More accurate targeting of the offending tissue may reduce the number of repeat catheter ablatio...

Abbott wins FDA nod for HeartMate 3 pump

Mon, 28 Aug 2017 13:00:10 +0100

Abbott (NYSE:ABT) said today that the FDA approved its HeartMate 3 implantable pump for heart failure patients awaiting a transplant. The approval is the latest for the HeartMate line of left ventricular assist devices first developed by Thoratec, which was later acquired by St. Jude Medical before a $25 billion merger brought it to Abbott earlier this year. Abbott said HeartMate 3 features full magnetic levitation for the pump’s impeller, aiming to cause less trauma to blood cells as they pass through the pump. Although it is smaller than its predecessor, Abbott claimed it has the industry’s largest “pump pathway.” The device won CE Mark approval in the European Union in October 2015. “Heart failure is a crippling and costly disease and the HeartMate 3 syst...

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

Numerate receives NIH funding to discover new anti-arrhythmic treatments

Wed, 09 Aug 2017 23:00:00 +0100

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has awarded a small business innovation research (SBIR) Phase I grant to Numerate to boost a new drug programme for cardiac arrhythmias. (Source: Pharmaceutical Technology)

Not all astrocytes in the brain are the same, study finds

Thu, 13 Jul 2017 16:53:00 +0100

From afar, the billions of stars in our galaxy look indistinguishable, just as the billions of star-shaped astrocytes in our brains appear the same as each other. But UCLA researchers have now revealed that astrocytes, a type of brain cell that supports and protects neurons, aren ’t all the same. While stars might be categorized by their size, age and heat, the supportive brain cells vary when it comes to shape, molecular machinery and functioning.The findings,published today in the journal  Neuron, should make it easier for researchers to study how astrocytes relate to disease, or to develop drugs that aim to target small subsets of astrocytes, said Baljit Khakh, a UCLA professor of physiology and neurobiology and the study’s senior author.“For 50 years, the textbooks have said th...

CathVision inks investment deal for electrophysiology system

Fri, 07 Jul 2017 19:38:05 +0100

Early-stage medical device company CathVision said today it inked a “multi-million venture investment” to support the development and marketing of its electrophysiology recording system designed for treating cardiac arrhythmia. The undisclosed investment came from Scandanavian-based VF Venture and Borean Innovation, Denmark-based CathVision said. “CathVision works in one of the fastest growing segments in medical technology. CathVision’s team has worked patiently and consistently with their product over a number of years, and we have followed the company for several years. I think CathVision represents an attractive investment target in a market with high activity,” VF Venture managing partner Tonni Bülow-Nielsen said in a prepared statement. “CathVisio...

Adverse Drug Event Causality Analysis (ADECA): a process for evaluating evidence and assigning drugs to risk categories for sudden death - Woosley RL, Romero K, Heise CW, Gallo T, Tate J, Woosley RD, Ward S.

Sat, 24 Jun 2017 10:39:00 +0100

Growing evidence indicates that many drugs have the ability to cause a potentially lethal cardiac arrhythmia, torsades de pointes (TdP). This necessitates the development of a compilation of drugs that have this potential toxicity. Such a list is helpful i... (Source: SafetyLit)

Tenth year of data on cardiac arrhythmia treatment launched at European congress

Sun, 18 Jun 2017 04:00:00 +0100

(European Society of Cardiology) The tenth year of data on cardiac arrhythmia treatment is being launched at EHRA EUROPACE - CARDIOSTIM 2017. (Source: EurekAlert! - Medicine and Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Medical News Today: Does the sound of airplanes raise blood pressure risk?

Wed, 14 Jun 2017 07:00:00 +0100

A new study investigates the effect of long-term exposure to aircraft noise on the risk of high blood pressure, cardiac arrhythmia, and stroke. (Source: Health News from Medical News Today)

Lessons from Fire Prevention: Why We Can Head Off Disease Without Sacrificing Cure

Sun, 11 Jun 2017 19:58:00 +0100

This insightful and data-filled evidence-based article from the Boston University School of Public Health  illustrates the work EMS can, and should, do to prevent disease where we cannot control curing it: Public health is concerned with creating a healthier world, preferably one where we prevent disease before it starts. This inevitably occasions grappling with our overwhelming investment in medicine and curative care, and arguing for a recalibration of our investment towards the social, economic, and cultural factors that promote health. We can educate people how to reduce their chances of suffering heart attacks, strokes and trauma. We can educate people of the significant risks of morbid obesity and the awful co-morbidity factors that accompany excessive weight: hypertension...

Acute alcohol intoxication in an eight weeks old infant - Frenkel Rutenberg T, Benacun M.

Thu, 01 Jun 2017 16:05:51 +0100

INTRODUCTION: Alcohol intoxication in infants is a life-threatening condition which requires early diagnosis and treatment. It may lead to multi-system injury, including mental deterioration, respiratory depression, cardiac arrhythmia, metabolic disorders ... (Source: SafetyLit)

Bathroom scales will inform about life threatening conditions

Tue, 16 May 2017 04:00:00 +0100

(Kaunas University of Technology) Weighing oneself has become one of the most common morning rituals. However, your weight is not the only message that can be delivered by your bathroom scales: the team of researchers at Kaunas University of Technology (KTU) Institute of Biomedical Engineering are developing the multifunctional scales, which can monitor your health and inform about potentially dangerous life conditions, such as arteriosclerosis or cardiac arrhythmia. (Source: EurekAlert! - Biology)

Arthur Moss Receives Heart Rhythm Society ’s Pioneer in Cardiac Pacing and EP Award

Fri, 12 May 2017 23:20:30 +0100

Arthur J. Moss, M.D., received the award for his dedication to understanding and treating electrical disturbances of the heart, including cardiac arrhythmias, sudden cardiac death, heart failure and Long QT syndrome. (Source: University of Rochester Medical Center Press Releases)

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

Abbott wins CE Mark for new TactiCath ablation catheter

Tue, 09 May 2017 15:05:15 +0100

Abbott (NYSE:ABT) said today that the TactiCath sensor-enabled ablation catheter it bought along with St. Jude Medical (NYSE:STJ) this year won CE Mark approval in the European Union. The Chicago-area healthcare giant said the new TactiCath device can be integrated with another St. Jude product, the EnSite Precision heart mapping system it launched earlier this year. “The goal in developing the TactiCath contact force ablation catheter, sensor enabled, was to provide the most innovative solution for treating atrial fibrillation and lead the way in clinical outcomes for patients with cardiac arrhythmias – even during long and complex ablation procedures,” electrophysiology medical director Dr. Srijoy Mahapatra said in prepared remarks. “Integration with the EnSite Pr...

Abbott wins CE Mark for Confirm Rx cardiac monitor

Mon, 08 May 2017 16:22:42 +0100

Abbott (NYSE:ABT) said today that its St. Jude Medical (NYSE:STJ) subsidiary won CE Mark approval in the European Union for the ConfirmRx insertable cardiac monitor, touting as the world’s 1st smartphone-compatible ICM. The continuous heart monitor is designed to work with St. Jude’s myMerlin mobile app to allow physicians to remotely follow  patients and diagnose arrhythmias. Abbott said it’s on the market in 10 “select” countries in Europe, with a full release slated for the 2nd quarter. The FDA is also reviewing the device, the Chicago-area healthcare giant said. “Incorporating wireless technology directly into our devices enhances the quality of remote monitoring and patient compliance,”cardiac arrhythmias & neuromodulation CMO Dr. M...

Abbott Announces CE Mark and First Use of the World's First Smartphone Compatible Insertable Cardiac Monitor

Mon, 08 May 2017 10:00:00 +0100

Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm RxTM Insertable Cardiac Monitor (ICM), the world's first smartphone compatible ICM that will help physicians identify difficult to detect cardiac arrhythmias, including atrial fibrillation (AF), to help guide therapy. Since CE Mark approval, adoption of the device has been strong and implants have occurred in 10 countries across Europe. (Source: eHealth News EU)

Abbott announces CE Mark and first use of the world's first smartphone compatible insertable cardiac monitor

Mon, 08 May 2017 10:00:00 +0100

Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm RxTM Insertable Cardiac Monitor (ICM), the world's first smartphone compatible ICM that will help physicians identify difficult to detect cardiac arrhythmias, including atrial fibrillation (AF), to help guide therapy. Since CE Mark approval, adoption of the device has been strong and implants have occurred in 10 countries across Europe. (Source: World Pharma News)

Digital health news briefs for 5/4/2017: CardioNet HIPAA settlement, Telemedicine lactation consulting

Thu, 04 May 2017 21:32:52 +0100

OCR settles HIPAA complaint with CardioNet.  CardioNet, one of the oldest companies in the mobile cardiac arrhythmia monitoring space, has agreed to pay the Office of Civil Rights $2.5 million and enter into a corrective action plan in the end result of a HIPAA breach investigation that's been going on since 2012. (Source: mobihealthnews)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Advanced Cardiac Therapies lands $45m round led by new PE shop Ajax Health

Tue, 02 May 2017 15:43:20 +0100

Ajax Health, the medical device portfolio management company newly formed by KKR and Aisling Capital, led a $45 million round for Advanced Cardiac Therapeutics and the next-generation ablation catheter it’s developing. Earlier today the private equity giants launched tapped Spirox chairman & CEO Duke Rohlen to lead Ajax Health. Rohlen, the former president of FoxHollow Technologies and the founder & former chief executive of CV Ingenuity, is also CEO at ACT. That Santa Clara, Calif.-based company said existing backer New Enterprise Assoc. and new investor Questa Capital Management also participated in the round, which is earmarked for a clinical program aimed at winning regulatory nods in the U.S. and Europe. “I am extremely pleased with the significant fina...

Binge drinking could trigger abnormal heart rhythms

Thu, 27 Apr 2017 17:29:16 +0100

Conclusion This cross-sectional study found binge drinking is associated with an increased risk of having an irregular heartbeat. However, the type of irregular heartbeat found was mainly sinus tachycardia, which isn't life threatening but involves the heart beating at an abnormally fast rate of over 100 heartbeats a minute. This research also has some notable limitations: The ECG recordings from the acute alcohol group were taken using a smartphone application operated outside the manufacturer's recommended environment. The lively atmosphere within the beer tent may have caused inaccurate recordings. The population recruited from Oktoberfest was varied in ethnic origin and only 69% were from Germany – it may not be appropriate to compare them with the KORA community population, w...

AliveCor raises $30m

Fri, 31 Mar 2017 20:08:52 +0100

Heart Societies update guidelines to support cardiac monitors for syncope patients

Fri, 24 Mar 2017 15:30:24 +0100

Medtronic (NYSE:MDT) said today that new guidelines from the American College of Cardiology, the American Heart Association and the Heart Rhythm Society now recommend the use of cardiac monitors for patients with syncope. The updated guidelines for patients with syncope, or unexplained fainting, was published online in the Journal of the American College of Cardiology, Circulation and HeartRhythm. Medtronic said that the new guidelines support the use of its Seeq MCT system, a wireless continuous external heart monitor that can be worn up to 30 days, and its Reveal Linq ICM with TruRhythm detection, an implantable monitor placed just beneath the skin which allows for wireless monitoring for up to 3 years. “The causes of syncope can be difficult to diagnose as episodes are usually i...

AliveCor raises $30m, launches Kardia Pro platform in U.S.

Thu, 16 Mar 2017 18:41:17 +0100

AliveCor said today that it landed $30 million in a series D funding round and that it released its artificial intelligence-enabled Kardia Pro platform in the U.S. The company’s platform enables doctors to remotely monitor their patients for early signs of atrial fibrillation, a common cardiac arrhythmia. “Heart disease is the No. 1 cause of death in the United States, claiming more lives than all forms of cancer combined. To manage heart disease and stroke risk, leading cardiologists want to see more than just ECGs from their patients,” CEO Vic Gundotra said in prepared remarks. “Kardia Pro tracks important measures of physiology like weight, activity and blood pressure, and, for the first time, AI technology is used to create a personal heart profile for each user, enabling use...

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

Abbott announces FDA approval of Flexibility < sup > TM < /sup > Ablation Catheter, Sensor Enabled < sup > TM < /sup > to advance the treatment of complex cardiac arrhythmias

Wed, 01 Mar 2017 21:27:00 +0100

- Sensor EnabledTM tool complements the EnSite PrecisionTM cardiac mapping system and expands Abbott's comprehensive advanced cardiac mapping and ablation portfolio (Source:

Abbott wins FDA nod for FlexAbility sensor-enabled ablation cath

Wed, 01 Mar 2017 17:14:13 +0100

Abbott (NYSE:ABT) said today it won FDA approval for its sensor-enabled FlexAbility ablation catheter designed for cardiac ablation procedures to treat atrial flutter. The sensor-enabled FlexAbility ablation catheter is the Abbott Park, Ill.-based company’s 1st designed to collect electrical current resistance and magnetic data to produce accurate mapping and assist in treating sites that trigger or sustain abnormal heart rhythms. “I am seeing an increasing number of patients with complex cardiac arrhythmias, which has created a strong need for advanced tools that can meet the needs of those patients. Sensor Enabled catheters, along with EnSite Precision cardiac mapping system, allow me to quickly identify and treat the arrhythmia, giving me the flexibility and accuracy I need ...

Must-watch: video showing murder of Kim Jong Nam

Wed, 22 Feb 2017 18:25:10 +0100

Discussion on toxicology discussion boards have brought up the following possibilities: Tetramine: Tetramethylenedisulfotetramine (TETS) is a rat poison that has been banned since 1984 but which — according to Wikipedia — is still used in China. It is a white powder that is slightly soluble both in water and DMSO, a solvent that could accelerate dermal absorption. TETS is a neurotoxin that acts as a GABA antagonist causing refractory status epileptics, coma, and death. There is no specific antidote. Aconite: This plant poison is used in several Chinese herbal medicines.Aconite is a sodium channel opener, causing gastrointestinal symptoms, perioral paresthesias, bradycardia, and cardiac arrhythmias. Onset after ingestion is reported to be 10 – 20 minutes. Scientific literature i...

Medtronic wins FDA clearance for CardioInsight 3D mapping tech

Wed, 01 Feb 2017 14:43:06 +0100

Medtronic (NYSE:MDT) said today that it won 510(k) clearance from the FDA for its CardioInsight Noninvasive 3D mapping system, which was designed to map irregular heart rhythms in the upper and lower chambers of the heart and provide electroanatomic 3D maps of the heart. The CardioInsight system is the 1st commercially available, noninvasive cardiac electrical mapping system in the world, according to Medtronic, and avoids the invasive steps of a traditional procedure to determine the origin of a patient’s irregular heart rhythm. Medtronic’s 3D cardiac mapping system employs a 252-electrode sensor vest, which is worn by the patient. The technology captures electrocardiogram signals from the chest and combines them with data from a CT scan of the heart. The vest allows for simul...

Atrial fibrillation more prevalent in dialysis patients than expected

Mon, 16 Jan 2017 14:14:31 +0100

Atrial fibrillation, which is the most common cardiac arrhythmia, is an important risk factor for strokes. A multi-centre study shows that the prevalence of atrial fibrillation in haemodialysis patients in Vienna is significantly higher than previously thought. Moreover, only half of the patients affected are treated with an anticoagulant. (Source: ScienceDaily Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Hypothermia Diagnosis and Treatment Could Save Lives

Fri, 13 Jan 2017 20:37:28 +0100

Hypothermia is a life threatening condition that may result in death. It is a drop in the core body temperature of less than 95°F (35° Celsius). This temperature is below what is required for normal metabolism and bodily function (Figure 1). The normal body temperature is between 97.7°F and 99.5°F (Fahrenheit) which is the same as 36.5°C and 37.5°C (Celsius). The body's thermoregulation mechanism adjusts to weather changes. Thermoregulation During extreme cold, the body receives a signal from sensory receptors. The signal will go up to the brain. The brain then sends a signal to the body to respond to the cold temperatures and attempts to maintain the core body temperature (Figure 2). This is necessary in order to provide the vital organs with the necessary heat to function prope...

Warmer Oceans Increase Likelihood Of Toxic Shellfish, Study Finds

Wed, 11 Jan 2017 20:33:09 +0100

The neurotoxin domoic acid inspired Alfred Hitchcock’s “The Birds” after hundreds of sooty shearwaters ingested the poison in the summer of 1961 and, well, lost their minds. The crazed birds likely consumed domoic acid via small fish like anchovies and sardines. It also tends to collect in shellfish, like clams, crabs and lobsters. And, according to a study published Tuesday in the Proceedings of the National Academy of Sciences, it may become more prevalent as oceans warm, threatening birds and humans alike. Researchers at Oregon State University, the University of Oregon, the National Oceanic and Atmospheric Administration, and the Oregon Department of Fish and Wildlife studied the prevalence of domoic acid over the past 20 years in the Pacific Northwest,...

Biotronik launches BioMonitor 2 subcutaneous heart monitor trial

Mon, 05 Dec 2016 18:40:49 +0100

Biotronik said today it enrolled the 1st patients in the BioInsight clinical study of its BioMonitor 2 heart monitor, which looks to investigate the feasibility implanting the BioMonitor 2 in office settings. The BioMonitor 2 device is designed for remote monitoring of patients with atrial fibrillation, syncope, bradycardia and tachychardia, Biotronik said. The device uses Biotronik’s ProMRI technology and is approved for full-body MRI scans at 1.5 and 3 tesla strength. “One of the benefits of BioMonitor 2 is the ease of the insertion procedure, which typically only takes a few minutes. In-office procedures can reduce patient’s and physician’s time, increase access to the device and reduce cost burdens for healthcare systems. Early insertion will likely also reduce th...

Macrophage-dependent IL-1 & #946; production induces cardiac arrhythmias in diabetic mice

Thu, 24 Nov 2016 05:00:00 +0100

(D'Or Institute for Research and Education) One of the most serious complications of diabetes, heart arrhythmias, is now on its way to be prevented and combated. Heart problems are responsible for 65 percent of the deaths related to diabetes. This work confirms that the increase in blood glucose causes a specific inflammation, which directly affects the heart. Here the authors propose new therapeutic tools that are promising to treat the heart disease caused by diabetes. (Source: EurekAlert! - Medicine and Health)

UPDATE: Apama Medical raises $20m

Fri, 18 Nov 2016 18:29:02 +0100

Updated to include new information from Apama Medical Novel catheter ablation tech developer Apama Medical said it raised a total of $19.7 million, with $13.2 million coming from a closed Series C round and $6.5 million from a debt facility with Silicon Valley Bank. Apama Medical is developing novel ablation catheter technology to combine “the best elements of existing ablation technology while incorporating additional unique features to address gaps in current technology,” according to it’s website. The Series C round was joined by Ascension Ventures, Medvance Incubator Partners, ONSET Ventures, Incept and various angel investors, the company said. “We are pleased to receive such strong support from our existing investors, which we attribute to the tremendous progr...

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

Genetesis lands $1m seed round for CardioFlux heart imaging device

Mon, 14 Nov 2016 18:34:43 +0100

Genetesis said today that it raised a $1.2 million seed round for its CardioFlux heart imaging device. Cincinatti-based Genetesis said the round was led by CincyTech and Mark Cuban’s Radical Investments and included Loud Capital, Danmar Capital, Wilson Sonsini Investment Company, Genetesis management and private angels. The CardioFlux device is designed to create a 3D map to characterize the heart’s underlying electrical activity in patients with myocardial ischemia, atrial fibrillation, ventricular tachycardia and other cardiac arrhythmias. The company said it plans to use the proceeds to scale its engineering, launch additional clinical studies and seek regulatory clearance from the FDA. Co-founder & CEO Peeyush Shrivastava is slated to present data from a clinical st...

Japan approves St. Jude Medical ’ s EnSite, TactiCath

Wed, 02 Nov 2016 18:53:24 +0100

St. Jude Medical (NYSE:STJ) said today it won Japanese MHLW approval for its EnSite Precision cardiac mapping system and its TactiCath irrigated ablation catheter. The Ensite cardiac mapping system is designed for use in ablation procedures to visualize and aid in catheter navigation in the heart, providing detailed anatomical models and maps, St. Jude said. The system is designed to aid in diagnosing arrhythmias, guiding therapy and providing expanded procedural options. The St. Paul, Minn.-based company’s TactiCath quartz irrigated ablation catheter is designed for ablation procedures to treat atrial fibrillation. St. Jude touted the device as being designed to allow for “more control” of force during ablation procedures to create “more effective lesions.”...

St. Jude launches EnSite Precision cardiac mapping system in EU

Wed, 05 Oct 2016 17:20:23 +0100

St. Jude Medical (NYSE:STJ) said today it fully launched its EnSite Precision cardiac mapping system and associated tools in Europe, expanding from an earlier limited release. The St. Paul, Minn.-based company touted more than 100 installations of the device across Europe so far, supporting more than 5,000 ablation procedures after a targeted release it expanded in April. “We collaborated with leading electrophysiologists to develop a cardiac mapping system that provides the automation, flexibility and precision needed during today’s ablation procedures. We are extremely pleased with how the physicians from these European sites have embraced the system and are excited to expand its availability as we seek more approvals,” chief medical officer Dr. Mark Carlson said in a pres...

Complex Fetal Care: Importance of Fetal Arrhythmias to the Neonatologist and Pediatrician

Thu, 29 Sep 2016 22:00:00 +0100

Sudden unexplained death during the perinatal period remains a major longstanding challenge. Recent advances in diagnostic techniques and genetic testing have provided evidence that a significant fraction of these deaths may result from lethal cardiac arrhythmias. In this article, we review current methods of diagnosing arrhythmia in the fetus and strategies for managing life-threatening arrhythmia throughout the perinatal period, including transitional care at the time of delivery. (Source: NeoReviews recent issues)

Medtronic touts CRT study showing heightened medication adherence

Mon, 19 Sep 2016 16:10:48 +0100

Patients implanted with cardiac resynchronization devices showed a greater rate of adherence to their medication regiments after their CRT devices were put it, according to a retrospective study Medtronic (NYSE:MDT) touted today. The analysis examined data from 4,512 patients who received CRT devices between January 2008 and December 2014, evaluating adherence to recommended medications before and after CRT implantation. Compliance increased 67% 2 years after CRT implantation when compared to 2 years pre-implantation, Fridley, Minn.-based Medtronic said. “These data support our commitment to understanding how we can continue to provide the best solutions for patients with heart failure. With some heart failure patients, CRT is a turning point in their treatment plan because – in ...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free. +5 | The top 5 medtech stories for September 14, 2016

Wed, 14 Sep 2016 19:00:19 +0100

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Light-based arrhythmia treatment skips the shocks Researchers at Johns Hopkins University and Germany’s University of Bonn showed that light can restore a normal heartbeat and replace electric shocks in patients at risk for arrhythmia, according to a press release from the Baltimore school. The work was published online yesterday in the Journal of Clinical Investigations and could 1 day be us...

Light-based arrhythmia treatment skips the shocks

Wed, 14 Sep 2016 13:58:34 +0100

Researchers at Johns Hopkins University and Germany’s University of Bonn showed that light can restore a normal heartbeat and replace electric shocks in patients at risk for arrhythmia, according to a press release from the Baltimore school. The work was published online yesterday in the Journal of Clinical Investigations and could 1 day be used to develop implantable defibrillators, the team suggested. A standard defibrillator uses electrical shocks to jump-start the heart when a patient experiences arrhythmia, a potentially deadly irregular heartbeat. The shocks can be painful and damage the heart tissue. Researchers at the University of Bonn turned to the emerging field of optogenetics, which uses light-sensitive proteins to modify electrical activity in cells. The Bonn team used beat...

Japan approves Medtronic ’ s Reveal Linq cardiac monitor

Wed, 14 Sep 2016 13:33:26 +0100

Medtronic (NYSE:MDT) wasted no time in launching its Reveal Linq cardiac monitor in Japan, saying it plans to launch the device there this month now that the device won approval from the Ministry of Health, Labor & Welfare. The Reveal Linq device is designed to be implanted beneath the skin on the upper left side of the chest for monitoring patients experiencing dizziness, palpitation, fainting or syncope, chest pain and cardiac arrhythmias. Billed as the world’s smallest cardiac monitor, it’s about ⅓ the size of a triple-A battery and is designed to work for 3 years using the company’s CareLink network. Its approval in Japan covers its use for monitoring unexplained syncope and cryptogenic stroke, the company said. Reveal Linq is also MR-conditional, meaning it’s safe f...

What Causes Hyperphosphatemia?

Mon, 12 Sep 2016 00:49:32 +0100

Discussion Constipation is a common problem in general pediatrics and its causes are numerous. It can cause acute and recurrent abdominal pain and is a cause of abdominal distention. Patients who are young, whose presentations are other than routine or who had complications should be invested for underlying causes of their constipation. This patient had undergone some evaluations in the past for constipation but because of the presentation of sepsis a more rigorous evaluation was undertaken. The differential diagnoses of the following can be found here: constipation, acute abdominal pain, recurrent abdominal pain, and abdominal distention. Hyperphosphatemia caused by retention of oral phosphate containing medications and hypertonic sodium phosphate enemas are known causes of hyperphosphat...

[In Depth] A painstaking overhaul for cardiac safety testing

Thu, 01 Sep 2016 22:00:00 +0100

It's a crucial step in drug development: testing a compound to gauge whether it might cause cardiac arrhythmia. For years, researchers and drug developers have worried that standard preclinical tests for cardiac safety are actually too conservative, and may lead drugmakers to abandon promising and safe treatments early in development. Since 2013, an international team of regulators, academic researchers, and drug companies have been validating a more sophisticated set of tests, known as the Comprehensive in vitro Proarrhythmia Assay (CiPA). That painstaking process is inching toward completion. In the coming weeks, a key component of that assay, based on stem cell–derived heart cells, will undergo blind testing on drugs with known risks at various academic and industry labs, and the CiPA...

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

[This Week in Science] Genetic underpinnings of atrial fibrillation

Thu, 01 Sep 2016 22:00:00 +0100

Author: Katrina L. Kelner (Source: ScienceNOW)

Influence of ambient temperature and diurnal temperature range on incidence of cardiac arrhythmias - Kim J, Kim H.

Wed, 31 Aug 2016 15:08:18 +0100

We investigated the association between ambient temperature and diurnal temperature range (DTR) and the exacerbation of arrhythmia symptoms, using data from 31,629 arrhythmia-related emergency department (ED) visits in Seoul, Korea. Linear regression analy... (Source: SafetyLit)

CyberHeart inks development deal with Japan ’ s National Cancer Center

Mon, 08 Aug 2016 18:05:00 +0100

Cardiovascular radiosurgery developer CyberHeart said today it inked its 1st development deal to install its CyberHeart system in Tokyo’s National Cancer Center, making it the 1st non-invasive cardiac radiosurgery treatment in Asia. The CyberHeart system is a non-invasive robotic assisted ablation treatment that uses image-guided tracking of intra-cardiac and other ablation targets for personalized treatments based on a patient’s anatomy, the Mountain View, Calif.-based company said. “We are excited to offer our patients the most advanced, painless and non-invasive treatment for cardiovascular conditions, and thrilled to be the first center in Asia to offer the use of this breakthrough technology. The CyberHeart system allows patients to undergo ablation for cardiac arr...

Mother's plea to test teens for cardiac arrhythmia after losing daughter to condition

Mon, 08 Aug 2016 16:02:38 +0100

John and Heather Reid, of Nottingham, have called for blanket heart testing for 12-to-39-year-olds after they lost their 16-year-old daughter Alexandra to an undiagnosed cardiac condition. (Source: the Mail online | Health)

Medical device maker VytronUS raises $49M to treat heart problems

Fri, 29 Jul 2016 18:42:39 +0100

< img src="*100xx278-278-0-0.jpg" > Medical device startup VytronUS raised $49 million in funding on Friday to help validate its imaging platform for the treatment of cardiac arrhythmias. Apple Tree Partners, New Enterprise Associates, BioStar Ventures and Windham Venture Partners participated in the Series C round. The Sunnyvale company has raised $101 million to date. CEO John Pavlidis heads up the business, which was founded in 2006. The VytronUS system creates a high-resolutio n image of the interior of the heart. "We have developed… < div class="feedflare" > < a href="" > < img src="" border="...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

VytronUS, Inc. Raises $49 Million in Series C Financing

Fri, 29 Jul 2016 13:26:23 +0100

SUNNYVALE, Calif., July 29, 2016 -- (Healthcare Sales & Marketing Network) -- VytronUS, Inc. ("VytronUS"), a privately held medical device company developing novel technologies for the treatment of cardiac arrhythmias, announced today that it ha... Devices, Cardiology, Venture CapitalVytronUS, Low-Intensity Collimated Ultrasound, LICU, atrial fibrillation (Source: HSMN NewsFeed)

InfoBionic raises $8m

Fri, 22 Jul 2016 22:02:37 +0100

Digital health startup InfoBionic raised $8.2 million in a new round of equity financing, according to an SEC filing posted this week. InfoBionic produces the MoMe Kardia wireless remote cardiac monitoring system designed to aid in the diagnosis of cardiac arrhythmias. Money in the round came from 55 anonymous sources and the company is hoping to bring in another $308,055 before closing it, according to an SEC filing. The company has yet to state how it intends to use funds raised in the round. In March, InfoBionic said it won FDA 510(k) clearance for its next-gen MoMe Kardia wireless cardiac remote monitoring system. The next-generation MoMe Kardia is a 3-in-1 single piece device that acquires and stores ECG and motion data and transmits them through the company’s cloud-based MoMe Soft...

InfoBionics, BioTelemetry each claim win in patent spat

Thu, 21 Jul 2016 17:31:55 +0100

Both BioTelemetry (NSDQ:BEAT) and digital health startup InfoBionic celebrated victory in their patent fight with each other over wireless cardiac monitoring technology. But the battle is far from over. Pennsylvania-based BioTelemetry disclosed that the Massachusetts District Court stopped InfoBionic from making, using, marketing or selling in the U.S., or importing into the country, any of its first-generation MoMe Kardia system products. BioTelemetry also pledged to continue “pending patent infringement claims” against the company’s second-generation MoMe Kardia system, plus claims involving “misappropriation of BioTelemetry’s trade secrets.” BioTelemetry alleges that this happened after “one or more” ex-Biotelemetry executives and employees joined InfoBionic and took pa...

Taking STEMI Recognition to the Next Level

Fri, 15 Jul 2016 19:39:00 +0100

FOR RELEASE July 18, 2016 A new online 12-lead ECG course at ECG Medical Training is helping paramedics, nurses, and physicians take STEMI recognition to the next level. The course was developed by cardiology blogger Tom Bouthillet and launched earlier this year. The curriculum is divided into 4 main sections. 12-Lead ECG Basics STEMI Recognition STEMI Equivalents STEMI Mimics There are 40 videos in all, averaging about 10 minutes in length. It is fully accredited and offers CMEs for paramedics, nurses, and physicians. “The literature shows that paramedics do a pretty good job when it comes to identifying clear-cut STEMI” says Bouthillet. “However, we tend to struggle a bit more when it comes to identifying the STEMI equivalents and STEMI mimics.” Almost all of the 12-lead ECGs i...

New study finds link between omega-3 supplementation and reduced hospital stays

Tue, 21 Jun 2016 04:00:00 +0100

(GOED) A new meta-analysis published in Clinical Nutrition found that cardiac surgery patients who received omega-3 polyunsaturated fatty acids (PUFAs) in advance of surgery experienced reduced postoperative cardiac arrhythmias and reduced the length of stay in the hospital by up to 2.4 days. The results are based on 11 RCT's with 1,038 patients. (Source: EurekAlert! - Biology)

Unintended Consequences: FDA Drug Safety Warning BackfiresUnintended Consequences: FDA Drug Safety Warning Backfires

Mon, 13 Jun 2016 16:29:17 +0100

FDA warnings to reduce the daily dosage of citalopram to 40 mg or less to avoid the possibility of cardiac arrhythmias not only failed to do so but also resulted in poor mental health outcomes. Medscape Medical News (Source: Medscape Psychiatry Headlines)

UPMC researchers shine light on common heart complication after lung transplantation

Thu, 26 May 2016 04:00:00 +0100

(University of Pittsburgh Schools of the Health Sciences) Cardiac arrhythmia is a common complication following lung transplantation, and one that has a significant negative impact on long-term patient survival. (Source: EurekAlert! - Medicine and Health)

CardioNXT raises $1.5m for novel cardiac ablation tech

Wed, 25 May 2016 18:17:42 +0100

Heart focused medical-technology company CardioNXT said today it raised $1.5 million in equity funding to support its platform of cardiac arrhythmia products. CardioNXT is developing products to improve the understanding of complex cardiac arrhythmias such as atrial fibrillation and to reduce the cost of cardiac catheter ablation procedures, the company said. Funds in the round came from Solas BioVentures as well as existing investors in the Westminster, Colo.-based company. “Our mission is to invest in solutions that enable people to lead longer and fuller lives.  Atrial Fibrillation affects 6.1 million Americans alone and many more people globally.  AFib has been linked to stroke and dementia due to pooling blood and resultant clots traveling to the brain from the heart.  The C...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

3 barriers keeping data from improving health outcomes

Fri, 20 May 2016 21:00:00 +0100

Access to actionable, real-time data can create opportunities for physicians to improve the health of their patients, but the current environment often prevents physicians from being able to access and use that data. Find out what three experts think the future holds for data usage and what they say needs to change first. How health data can—and does—save lives Experts recently spoke to the health IT community about current and future uses of data at Health Datapalooza in Washington, D.C. Though there are issues in the current health system that cause problems for data usage in practice, the panelists were first and foremost optimistic about the future. “We are using data to save people’s lives,” said David T. Feinberg, MD, president and CEO of Geisinger Health Systems. For... +5 | The top 5 medtech stories for April 22, 2016

Fri, 22 Apr 2016 19:00:55 +0100

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. SRI International spins off wearable robotics biz Superflex Research group SRI International said yesterday it is spinning off a wearable robotics focused biz Superflex, which aims to develop robotics to enhance the human musculoskeletal system. The technology at the base of newly spun-off Superflex was originally developed for the “Warrior Web” program, a DARPA-funded effort to enhance sol...

Boston Scientific wins rehearing in PTAB case against UAB

Fri, 22 Apr 2016 13:55:48 +0100

The U.S. Patent Trial and Appeal board granted a rehearing request to Boston Scientific (NYSE:BSX) for an inter partes review of a patent held by UAB Research Foundation related to treating cardiac arrhythmias. Boston Scientific filed a petition for an inter partes review over claims related to the patent and was denied last September, but was granted the request for rehearing yesterday after the board deemed that the company “established a reasonable likelihood of prevailing on its assertions” over claims that the patent in question could be anticipated. The rehearing was granted based on an analysis that identified misplaced decimal point in the original decision, according to court documents. The spat spans back to 2014, when the University of Alabama at Birmingham and the...

Study: Medtronic touts increased AF detection with Reveal Linq system

Wed, 20 Apr 2016 18:54:11 +0100

Medtronic (NYSE:MDT) today released 1-year results from a study of patients who experienced a cryptogenic stroke, claiming that its Reveal Linq insertable cardiac monitor was able to detect atrial fibrillation at a greater rate than previously reported in a 2014 clinical trial. Results from the real-world study were presented at the 68th American Academy of Neurology’s annual meeting in Vancouver, Canada. The Reveal Linq device is designed to be implanted beneath the skin on the upper left side of the chest and is indicated for monitoring patients experiencing dizziness, palpitation, fainting or syncope, chest pain and cardiac arrhythmias. Billed as the world’s smallest cardiac monitor, it’s about ⅓ the size of a triple-A battery, Medtronic said, and is designed to work for 3 ...

St. Jude Medical Announces New EnSite Precision Cardiac Mapping System Limited Market Release in Nine Countries Across Europe Since CE Mark

Tue, 19 Apr 2016 15:54:47 +0100

Prominent European electrophysiology labs and hospitals have embraced the next generation mapping system’s automation, flexibility and precision for tailoring treatment for patients with cardiac arrhythmias ST. PAUL, MN--(Healthcare Sales & Marketing Ne... Devices, Cardiology, Product LaunchSt. Jude Medical, EnSite Precision, electrophysiology (Source: HSMN NewsFeed)

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

AtriCure Announces 510(k) Clearance for the cryoFORM(TM) Cryoablation Probe

Tue, 12 Apr 2016 12:59:52 +0100

Clearance brings an even more flexible probe to the U.S. market for use in a variety of surgical interventions to treat cardiac arrhythmias. Product was launched in Europe in October 2015 MASON, Ohio--(Healthcare Sales & Marketing Network)--AtriCure,... Devices, Interventional, Cardiology, FDAAtriCure, atrial fibrillation, cryoFORM, cryoablation (Source: HSMN NewsFeed)

InfoBionic wins 510(k) for next-gen MoMe Kardia cardiac monitor

Wed, 16 Mar 2016 19:19:43 +0100

Digital health startup InfoBionic said today it won FDA 510(k) clearance for its MoMe Kardia wireless cardiac remote monitoring system designed to aid in the diagnosis of cardiac arrhythmias. The next-generation MoMe Kardia is a 3-in-1 single piece device that acquires and stores ECG and motion data and transmits them through the company’s cloud-based MoMe Software system for analysis, the Lowell, Mass.-based company said. “We’re thrilled to announce FDA 510(k) clearance to market for MoMe Kardia, which supports our mission to create superior patient monitoring solutions for arrhythmia detection and chronic disease management. MoMe Kardia is a 3-in-1 device that seamlessly transitions between Holter, Event and MCT modes remotely, streamlining patient monitoring time wit...

FDA Clears MoMe Kardia Wearable EKG Cardiac Arrhythmia Monitor

Wed, 16 Mar 2016 14:16:44 +0100

InfoBionic, Inc. today announced that it received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for MoMeKardia, a wireless, remote monitoring system designed to aid physicians in their diagnosis of cardiac arrhythmias in patients with a demonstrated need for cardiac monitoring. (Source: Medical Design Online News)

Optogenetic Light Crafting Tools for the Control of Cardiac Arrhythmias

Thu, 10 Mar 2016 23:00:00 +0100

The control of spatiotemporal dynamics in biological systems is a fundamental problem in nonlinear sciences and has important applications in engineering and medicine. Optogenetic tools combined with advanced optical technologies provide unique opportunities to develop and validate novel approaches to control spatiotemporal complexity in neuronal and cardiac systems. Understanding of the mechanisms and instabilities underlying the onset, perpetuation, and control of cardiac arrhythmias will enable the development and translation of novel therapeutic approaches. Here we describe in detail the preparation and optical mapping of transgenic channelrhodopsin-2 (ChR2) mouse hearts, cardiac cell cultures, and the optical setup for photostimulation using digital light processing. (Source: Springer...

What Your Tongue And Tonsils Could Tell You About Your Sleeping Habits

Wed, 09 Mar 2016 19:08:39 +0100

Your dentist might be able to tell if you're having trouble sleeping.  Yes. A new study published in the Saudi Medical Journal found that the size of a person's tonsils may indicate their risk for obstructive sleep apnea, a condition in which blocked upper airways cause breathing to stop and restart repeatedly during sleep. Tongue indentations, or teeth imprints on the tongue that suggest it's too big for the mouth, may also be a sign.  More than 18 million adults in the United States are affected by OSA. Since people with the condition are often suffering from interrupted and reduced sleep, it can lead to fatigue, irritability, and trouble concentrating. In severe cases, the disorder can lead to learning and memory difficulties, heart attack, congestive heart failure, card...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Lyme: The Infectious Disease Equivalent of Cancer, Says Top Duke Oncologist

Fri, 19 Feb 2016 16:50:57 +0100

Last week, I mentioned the case of Dr. Neil Spector, whose long-undiagnosed Lyme Disease resulted in irreversible heart failure and ultimately, a heart transplant. Dr. Spector, author of Gone in a Heartbeat: A Physician's Search for True Healing, is the Sandra Coates Associate Professor of Medicine and Associate Professor of Pharmacology and Cancer Biology at Duke University School of Medicine. As the Director of Developmental Therapeutics at the Duke Cancer Institute, he's a leader in applying translational research to the clinical development of molecularly targeted personalized cancer therapies. Here, Dr. Spector shares his story, explains what Lyme and cancer have in common (hint: a LOT), and encourages us with his vision for the future. Like so many of us, your Lyme was missed by mu...

Some heart drugs and antibiotics show effective in fighting cancer

Tue, 09 Feb 2016 09:00:00 +0100

North American researchers have identified drugs that showed promising perspectives in treating cancers, according to a recent study published in Cancer Research. These drugs are normally used to treat other diseases, such as heart failure, cardiac arrhythmia, and infections. (Source: World Pharma News)

Here's Some Good News About Coffee And Your Heart

Wed, 27 Jan 2016 21:27:57 +0100

Sip your coffee with peace of mind: A new study published in the Journal of the American Heart Association has found that caffeine doesn't cause heartbeat irregularities, despite what we've heard in the past. Researchers at the University of California San Fransisco assessed the coffee, tea and chocolate intake of 1,388 healthy men and women over a year-long period. During this time, participants also wore a portable device that monitored their heart rhythm 24 hours a day.  Sixty-one percent of participants reported drinking or eating more than one caffeinated item every day, yet the heartbeat monitors did not detect extra heartbeats in those who ingested higher amounts of caffeine. This led researchers to conclude that caffeine intake has little effect on heartbeat. Why is this impo...

EMS Agencies Need to Have EAP Resources to Address Stress and Reduce Suicides

Mon, 21 Dec 2015 17:59:00 +0100

We battle a lot of demons in EMS. We battle cardiac arrhythmias in an attempt to reverse their negative effects on the heart. We battle infections by taking preventive actions to ensure we, and our patients, don’t succumb to its predictable damage. And we battle time with trauma patients, taking rapid action to prevent irreversible shock. But yet, we’re a stubborn, proud breed that does very little to help ourselves battle one of our worst demons: stress. EMS, fire, rescue and law enforcement attracts compassionate and physically strong people. But some responders feel that admitting to suffering stress because of what they’ve seen or experienced in the field is somehow a show of weakness. It’s not. By the nature of what we do, we’re often labeled as “adrenaline junkies.” Tha...

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

iRhythm launches iOS app for its cardiac patients, but it doesn’t connect to its wearable

Wed, 18 Nov 2015 14:01:21 +0100

iRhythm Technologies, maker of the Zio peel-and-stick wearable heart monitor, has launched a patient-facing companion app on iOS, called myZio, as well as a website, called The app and website allow wearers to track additional health data. They don’t display data collected by the Zio patch. These are the first patient-facing data offerings that the company, which commercially launched Zio in […] (Source: mobihealthnews)

Common antibiotics increase risk of cardiac arrhythmias, cardiac death

Mon, 09 Nov 2015 05:00:00 +0100

(American College of Cardiology) Macrolides -- a group of commonly used antibiotics for bacterial infections like pneumonia, bronchitis, and some sexually transmitted diseases -- are associated with a small but statistically significant increased risk of sudden cardiac death, according to a meta-analysis of 33 studies involving more than 20 million patients published today in the Journal of the American College of Cardiology. (Source: EurekAlert! - Infectious and Emerging Diseases)

Use of flumazenil and naloxone in poisoned patients

Tue, 03 Nov 2015 04:08:44 +0100

4 out of 5 stars Flumazenil, naloxone and the ‘coma cocktail’ Sivilotti MLA Br J Clin Pharmacol 2015 Aug 7 [Epub ahead of print] Abstract This very smart paper reviews factors affecting the clinical use of two antidotes that reliably reverse  coma caused by two major classes of poisons: flumazenil for benzodiazepines, and naloxone for opiates. Both these antidotes are specific, rapid-acting, short-lived, and titratable. However, significant adverse effects have been associated with each of them. Unwise or overly aggressive administration of flumazenil can cause acute benzodiazepine withdrawal, agitation, seizures, and fatal cardiac arrhythmias. Since many of the severe adverse effects occur in cases of mixed overdoses, use is generally discouraged in the comatose poisoned pat...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

A fatal case of acute butane-propane poisoning in a prisoner under psychiatric treatment: do these 2 factors have an arrhythmogenic interaction, thus increasing the cardiovascular risk profile? - Gioia S, Lancia M, Bacci M, Suadoni F.

Tue, 06 Oct 2015 00:56:50 +0100

Sudden death due to inhalation of aliphatic hydrocarbons such as butane and propane is well described in the literature. The main mechanism involved is the induction of a fatal cardiac arrhythmia. This phenomenon is frequently associated with prisoners who... (Source: SafetyLit: All (Unduplicated))

Studying cardiac arrhythmias in nematodes

Fri, 02 Oct 2015 12:23:05 +0100

A simple model using the nematode Caenorhabditis elegans has been developed that can be used to test substances for treating genetically-mediated cardiac arrhythmias. They used the nematode feeding apparatus for this purpose, a rhythmically active muscle pump that resembles the muscle cells in the mammalian heart. This could be an important step on the road to personalized treatment. (Source: ScienceDaily Headlines)

Scientists may have method to predict, prevent heart arrhythmias

Mon, 28 Sep 2015 18:32:13 +0100

Stephen FellerMONTREAL, Sept. 28 (UPI) -- Researchers have found a way to predict abnormal heartbeats in cardiac arrhythmia patients who have a condition called long QT syndrome. (Source: Health News -

Predicting arrhythmias so as to prevent them

Mon, 28 Sep 2015 13:34:29 +0100

Researchers have discovered how to predict some cardiac arrhythmias several steps before they even occur. It's a finding that could lead to an improved cardiac device, with equipment designed to detect when arrhythmias are about to occur and then act to prevent them, investigators say. (Source: ScienceDaily Headlines)

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

Biotronik launches 2 new studies

Wed, 12 Aug 2015 15:24:46 +0100

Biotronik announced 2 new studies last week that are slated to examine the company’s CRT-D device and BioMonitor implanted cardiac monitor. A 277-patient BioContinue clinical trial will examine the risk of ventricular arrhythmias after CRT-D replacement, enrolling patients over 2 years at 40 centers across 8 countries, the company said. Biotronik said the trial will be the 1st to investigate defibrillator back-up following device placement in heart failure patients with a primary indication for cardiac resynchronization therapy defibrillators. Patients in the trial will be implanted with Biotronik’s CRT-Ds and assessed for the rate of ventricular tachyarrhythmias over 2 years. Biotronik said that it looks to evaluate the risk of VTA or ventricular fibrillation after replacement...

Takatsuki General Hospital Performs First Procedure With Stereotaxis Niobe(R) ES Technology in Japan

Wed, 08 Jul 2015 15:49:46 +0100

ST. LOUIS, July 8, 2015 -- (Healthcare Sales & Marketing Network) -- Stereotaxis, Inc. (STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced today that the first procedure with its Niobe(R) ES magnetic navig... Devices, CardiologyStereotaxis, Niobe ES, Niobe, cardiac ablation, navigation system (Source: HSMN NewsFeed)

SentreHeart wins FDA nod for Lariat trial

Fri, 26 Jun 2015 12:00:00 +0100

SentreHeart said yesterday it won FDA investigational device exemption approval to begin enrolling subjects in a clinical trial of its Lariat device. The Amaze trial will evaluate the use of the Lariat for the ligation of the left atrial appendage as an adjunctive treatment to ablation in patients with persistent atrial fibrillation, the company said. “The LAA is an important site for atrial fibrillation initiation and persistence, and its exclusion using the Lariat device as an adjunct to conventional ablation could be a major breakthrough in decreasing recurrence in patients with persistent atrial fibrillation. The Amaze trial is rigorously designed and we believe will further validate the mechanical and electrical isolation benefits of the Lariat device, which has the potential t...

Consensus paper on patient preferences for arrhythmias management published

Wed, 24 Jun 2015 14:02:42 +0100

A unique consensus paper on patient preferences for arrhythmias management has been published. Cardiac arrhythmias can have a big impact on quality of life. Patients with ventricular arrhythmias, for example, may be banned from sports and driving. Those with an implantable cardioverter defibrillator (ICD) need to weigh the longevity they would gain with the device against the potential for a protracted death from progressive heart failure when deciding whether or not to have it switched off towards the end of life. (Source: ScienceDaily Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

First ESC recommendations for arrhythmias, chronic kidney disease published

Wed, 24 Jun 2015 14:02:40 +0100

Significant interactions occur between the heart and kidney, and even mild kidney disease is associated with an increased risk of cardiovascular disease. Sudden cardiac death is the most common cause of death in dialysis patients including children, accounting for 50% of cardiac deaths and 25% of all deaths. Now experts have released recommendations for patients with cardiac arrhythmias and chronic kidney disease. (Source: ScienceDaily Headlines)

6 Human Foods You Should Never Feed Your Cat

Wed, 24 Jun 2015 11:00:19 +0100

His tiny whiskers and swishy tail are so sweet it can be hard to resist giving him whatever he wants, but there are certain foods you should never feed your cat. Many human foods can put your little guy at risk for gastrointestinal problems, restlessness and worse. As the devoted pet owner that you are, the safest bet is to teach your cat that the food on the dinner table is for people only, and the food in his bowl can be enjoyed to the fullest. There are certain human treats you and your cat can share -- really small servings of cooked vegetables and fish are OK for kitties, for example. But when in doubt, it's best to stick to the veterinarian-approved eats, and to always consult your vet before introducing something new into your pawed pal's diet. Best Friends Animal Society, a Utah an...

First ESC recommendations for arrhythmias and chronic kidney disease published

Wed, 24 Jun 2015 04:00:00 +0100

(European Society of Cardiology) The first ESC recommendations for patients with cardiac arrhythmias and chronic kidney disease are presented today1 at EHRA EUROPACE - CARDIOSTIM 2015 and published in EP Europace.2 (Source: EurekAlert! - Medicine and Health)

AJMC to Name Emerging Leader Award in Honor of Seema S. Sonnad, PhD

Fri, 12 Jun 2015 11:50:14 +0100

Seema S. Sonnad, PhD, associate editor of The American Journal of Managed Care, died May 27, 2015, after suffering a cardiac arrhythmia during an ultramarathon. A new award for an emerging leader in...(PRWeb June 10, 2015)Read the full story at (Source: PRWeb: Medical Pharmaceuticals)

HRS 2015: SentreHeart's Lariat device leads to 20% leak rate

Thu, 14 May 2015 12:00:00 +0100

Data from a study on patients whose left atrial appendage was treated with SentreHeart's Lariat ligation device show that 20% of patients developed leaks, with 3 leading to neurological events. A study by researchers from the Texas Cardiac Arrhythmia Institute revealed a 20% rate of atrial leak development after 1 year in patients treated with SentreHeart's Lariat ligation device. SentreHeartNews Well, Cardiac Implants, HRS 2015, Strokeread more (Source: Mass Device)

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

My Conversation With Sleep Apnea Expert Richard Schwab

Tue, 28 Apr 2015 16:26:13 +0100

Dr. Richard Schwab is a professor of medicine at the Hospital of the University of Pennsylvania. His groundbreaking research has used innovative imaging techniques to study the development of sleep apnea (when tissues in the mouth close during sleep, resulting in repeated airway obstructions and associated oxygen drops). In our conversation, he shared his insights on the most important facts in sleep apnea research: the high prevalence of the disorder, how obesity and alcohol can cause sleep apnea, the resulting cardiovascular problems, and the importance and ease of treatments. Here is a lightly edited transcript of our conversation. What are the primary risk factors and consequences of sleep apnea? The big-picture message: Sleep apnea is really common. More than 18 million Americans su...